BI-10N

• CAT Number: I023344
• CAS Number: 1149753-56-9
• Molecular Formula: C26H34N6O2S
• Molecular Weight: 494.65
• Purity: 98%
• Synonyms: BI-10N; BI-10-N; BI10N; BI 10N; BI 10 N
• Target: Itk
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: N-[5-[[[(2S)-3,3-dimethylbutan-2-yl]amino]methyl]-1-(2-hydroxy-2-methylpropyl)benzimidazol-2-yl]-5-(1H-pyrazol-4-yl)thiophene-2-carboxamide
• InChI: InChI=1S/C26H34N6O2S/c1-16(25(2,3)4)27-12-17-7-8-20-19(11-17)30-24(32(20)15-26(5,6)34)31-23(33)22-10-9-21(35-22)18-13-28-29-14-18/h7-11,13-14,16,27,34H,12,15H2,1-6H3,(H,28,29)(H,30,31,33)/t16-/m0/s1
• InChIKey: MUAICZWSFWUFNA-INIZCTEOSA-N
• SMILES: C[C@@H](C(C)(C)C)NCC1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC=C(S3)C4=CNN=C4)CC(C)(C)O

BI-10N（Cat No.:I023344）is a selective small molecule inhibitor that targets a specific enzyme or protein involved in cellular signaling pathways. While detailed information on BI-10N’s precise mechanism is limited, it has been studied for its potential therapeutic applications in cancer and other diseases where abnormal cell signaling plays a key role. It is often investigated in preclinical research to explore its effects on tumor growth, angiogenesis, or immune modulation. Further clinical studies are needed to determine its safety, efficacy, and specific therapeutic potential for various conditions.